Blog

Introducing SCN2A Insights

Trailer: SCN2A Insights

Listen to SCN2A Insights to keep up to date with the latest research in SCN2A, genetic epilepsy and rare genetic disorders.

Hosted by Kris Pierce and David Cunnington, parents of Will, who has SCN2A.

Leave a review and subscribe via Apple Podcasts. 

You can also find SCN2A Insights on Spotify, and Google Podcasts or in your podcast app

Regular Hosts:

Ms Kris Pierce RN MHSc MWellness, is a rare disease advocate and mother to Will who has SCN2A. Kris has held a range of board, project management, advocate and consumer representative roles and has been instrumental in working with local, state and federal governments to secure funding for multi-million dollar projects. Kris is highly skilled in building teams to work together collaboratively and is a co-founder of Genetic Epilepsy Team Australia (GETA) and SCN2A Australia, and a RARE Global Advocacy Leadership Council member.

Follow Kris on LinkedIn or Twitter.

Dr David Cunnington is a sleep physician and father to Will who has SCN2A. He is director of Melbourne Sleep Disorders Centre, and co-founder and contributor to SleepHub. David trained in sleep medicine both in Australia and at Harvard Medical School in the United States. David’s clinical practice covers all areas of sleep medicine and he is actively involved in training health professionals in sleep. David is a regular commentator on sleep, both in traditional and social media.
Follow David’s posts on sleep on Facebook or Twitter

Transcript:

Welcome to SCN2A Insights. Bringing you the latest research and clinical updates onSCN2A and genetic epilepsy from around the world.

Hi I’m David Cunnington and I’m Kris Pierce. Our son Will has SCN2A. One of thehardest things we faced as parents throughout the years is not knowing. Not knowingour son’s diagnosis. Not knowing what the future holds and not knowing how we canhelp Will and others with SCN2A. As parents and caregivers we want to do everythingwe can to support researchers to find a cure for SCN2A. The best way to do this iswork in collaboration with the patient community around the globe.

That’s why we’re starting this podcast. By interviewing researchers, clinicians, industryrepresentatives and members of the patient community we hope to better informeveryone working on and impacted by SCN2A.

Keep up to date with the latest updates by subscribing to this podcast.

Get regular updates on SCN2A through SCN2A Australia’s Facebook or Twitter @SCN2AAustralia.

Leave a Reply